🔎 Trials Near Me

Beranda › Penyakit Alzheimer › Indiana › Indianapolis

Uji klinis Penyakit Alzheimer di Indianapolis, IN

14 studi untuk Penyakit Alzheimer mencari peserta di lokasi sekitar Indianapolis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Dominantly Inherited Alzheimer Network (DIAN)

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Indiana University-Indiana Alzheimer Disease Center, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT00869817

Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

Menerima peserta
  • Eskenazi Health, Indianapolis
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05643144

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Menerima pesertaFase 4
  • Josephson Wallack Munshower Neurology P.C., Indianapolis
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07633470

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Menerima pesertaFase 2
  • Indiana University Health Neuroscience Center, Indianapolis
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589595

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Menerima pesertaFase 3
  • Josephson Wallack Munshower Neurology, PC, Indianapolis
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06976203

A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD

Menerima pesertaFase 1
  • Clinical Trial Site, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05231785

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Menerima pesertaFase 2/3Sukarelawan sehat diterima
  • Indiana University School of Medicine, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Menerima pesertaFase 2/3Sukarelawan sehat diterima
  • Indiana University School of Medicine, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT06647498

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Menerima pesertaFase 3
  • Care Access - South Indianapolis, Indianapolis
  • Josephson Wallack Munshower Neurology, PC, Indianapolis
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07602582

Trial-Ready Cohort-Down Syndrome (TRC-DS)

Menerima pesertaStudi observasional
  • Indiana University, Indianapolis
Usia 25 hingga 55 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT04165109

Late Onset Alzheimer's Disease

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • NCRAD at Indiana University, Indianapolis
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT05010603

Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study

Menerima peserta
  • Indiana University, Indianapolis
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT05573490

Nicotinic Acid for the Treatment of Alzheimer's Disease

Menerima pesertaFase 1/2
  • IU Health Neuroscience Center, Indianapolis
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT06582706

I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

Menerima peserta
  • IU Health, Indianapolis
  • Community Health Network, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Nov 2025 · NCT05733520

Uji klinis Penyakit Alzheimer di kota lain

Studi lain di Indianapolis

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.